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Abstract
Digital self-tracking is rising, including tracking of menstrual cycles by women using fertility tracking apps (FTAs). However,
little is known about users’ experiences of FTAs and their relationships with them. The aim of this study was to explore
women’s uses of and relationships with FTAs. This exploratory study employed a mixed methods approach, involving the
collection and analysis of an online survey and follow-up interviews. Qualitative analysis of survey and interview data
informed hypothesis development. Online surveys yielded 241 responses and 11 follow-up interviews were conducted. Just
over a third of women surveyed had experience of using FTAs (89/241) and follow-up interviews were conducted with a
proportion of respondents (11/241). Four main motivations to use FTAs were identified: (a) to observe cycle (72%); (b) to
conceive (34%); (c) to inform fertility treatment (12%); and (d) as contraception (4%). Analysis of the free-text survey
questions and interviews using grounded theory methodology highlighted four themes underpinning women’s relationships
with FTAs: (a) medical grounding; (b) health trackers versus non-trackers; (c) design; and (d) social and ethical aspects.
Participants who used other health apps were more likely to use FTAs (p¼ 0.001). Respondents who used contraception
were less likely to use FTAs compared with respondents who did not use contraception (p¼ 0.002). FTA usage also decreases
(p¼ 0.001) as age increases. There was no association between FTA usage and menstrual status (p¼ 0.259). This research
emphasises the differing motivations for FTA use. Future research should further explore the diverse relationships between
different subgroups of women and FTAs.
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Introduction
Overview
Fertility tracking apps (FTAs) are smartphone or tablet
applications that allow users to record the dates of their
menstrual cycles, as well as additional information,
such as mood, symptoms, sexual activity and medica-
tions. FTAs claim to predict fertility windows based on
menstrual cycle data, which may help women who
are either wishing to conceive or trying to avoid con-
ceiving. FTAs may also assist women and their fertility
consultant when planning start dates for fertility treat-
ment as they can provide menstrual cycle information
to review at their ﬁngertips, which may oﬀer insights
or patterns that memory or verbal testimony alone
could not.
Health apps
With increased smartphone usage, people have easier
access to health information and, in turn, there has
been an increase in people seeking health information
electronically, developers providing health information
digitally and health professionals recommending health
apps to patients as part of preventive medicine and
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self-care regimens.1 Health apps include smartphone
applications that can be downloaded and allow those
who use them to track, monitor and act on their physio-
logical, psychological or social health data. This is con-
sistent with the emphasis of health professionals in
recent years to assist people to self-manage their
health, especially long-term conditions.
Health apps can empower users to monitor and
manage their own health2 and using them is becoming
common practice. For example, a study in the USA
found that 58% of mobile phone users have down-
loaded a health app.3 But it is not clear to what
extent the available technologies are based on clinical
evidence or integrated into formal health and social
care services. Whilst information collected via these
technologies might be informally shared with health-
care providers or used as tools to comply with medical
advice, they are not yet considered medical-grade
devices and are not governed by any regulatory guide-
lines. However, they are beginning to be recommended
by some health professionals.4,5
A fast-emerging niche of the ‘quantiﬁed self’ move-
ment (also known as ‘lifelogging’, which involves indi-
viduals incorporating technology into data acquisition
on aspects of their daily life) is fertility tracking.6 Apart
from ‘activity trackers’, FTAs are the most frequently
downloaded health app in the Apple App Store.7
Fertility tracking may also assist those under ‘expectant
management’ (clinically advised to continue trying to
conceive for a prescribed period) to time sexual inter-
course around the fertile window.
History of fertility tracking
Although FTAs are a relatively new concept, the act
of fertility tracking itself is not. Women have historic-
ally used the fertility awareness method (FAM) to docu-
ment their menstrual cycles with pen and paper but now,
with increasing smartphone use, it is possible to track
via apps. It is often used to plan activities around men-
strual bleeding and sexual intercourse around fertile
days to plan or avoid pregnancy. Comparative eﬃcacy
of the FAM of contraception remained
unknown.8 However, the FAM is a less eﬀective form
of contraception than other methods such as the intra-
uterine device (IUD).9 The FAM method requires
women to monitor changes such as basal body tempera-
ture, cervical mucus or cervical position.
FTAs
There is emerging research on the eﬃcacy of FTAs as
methods of contraception.10 For example, a recent
study found that the eﬃcacy of a contraceptive mobile
application is higher thanusually reported for traditional
fertility awareness-basedmethods and suggested that the
applicationmaycontribute to reducing theunmetcontra-
ceptive planning needs for women.11 Another study
based on the data of a web-based service for the FAM
discussed theadvantagesofadaptingnatural familyplan-
ning to information technology-basedmethods by allow-
ing fertility to be viewed as a simple bar chart.12
However, the accuracy of web-based and app-based
platforms in general13 and for predicting fertile win-
dows to aid conception14,15 has been questioned. One
study, which evaluated the features and functionality of
FTAs highlighted the lack of health professional and
evidence-based input.16 The importance of substantiat-
ing claims around fertility and contraception with clin-
ical evidence is highlighted.11 However, some apps have
been found to be more accurate than others, particu-
larly those that use symptothermal methods to calcu-
late fertility windows.17
FTA market and regulation
Currently, there is no single regulatory body (local,
national or international) approving FTAs before
they enter the market; therefore, there is a huge vari-
ance in how ‘medically sound’ each app is. Women
could have vastly diﬀerent experiences using these
apps depending on which one they use and how they
use it. It is not known, perhaps beyond commercially
sensitive market research conducted by provider com-
panies, how women select an app and whether clinical
endorsement is important to users.
Whilst conducting this research, it was announced
that Natural Cycles (www.naturalcycles.com/en) had
been approved as a recommended form of contracep-
tion in the European Union by the UK’s Medicines and
Healthcare products Regulatory Agency.18 This is the
ﬁrst step towards FTAs being approved and recom-
mended by healthcare professionals as a form of
contraception.
Potential implications of app usage
Although an interest in digital data in popular and
research cultures is now evident, we still do not know
enough about how people interact with and use the
digital health data that they generate.19 It is important
to improve our understanding of the uses of and rela-
tionships with health and digital technologies as we live
in a world where it is almost impossible to avoid inter-
actions with them. Research about FTAs may enable
new insights into understudied aspects of how female
bodies are experienced and understood. FTAs may
improve women’s ability to manage their reproductive
health information and communicate with their doctors
and partners.
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Research aim
The aim of this exploratory study was to explore
women’s uses of and relationships with FTAs in order
to independently and scientiﬁcally inform the design
and development of the next generation of FTAs.
Methodology
Study design
A mixed methods study, involving collection, analysis
and synthesis of data obtained through an online
survey using closed and open questions (quantitative
and qualitative) and follow-up interviews (qualitative),
was employed. Both quantitative and qualitative ana-
lysis informed hypothesis development. Hypotheses
were developed following the analysis of survey data
(descriptive statistics, grounded theory) and interview
data (grounded theory), at which point the quantitative
data were tested against the hypotheses for signiﬁcance.
Data collection involved a sequential approach (see
Appendix A).
Online survey. Following ethical approval by the
University of Aberdeen’s College Ethics Review
Board (CERB), a survey was created using
SurveyMonkey (www.surveymonkey.co.uk), a secure
online platform, in March 2017 (see Appendix B for
full study protocol). Participants were recruited
online, primarily via social media platforms Facebook
(www.facebook.com) and Twitter (www.twitter.com)
The online survey was shared on the social media
accounts of the Fertility Network UK charity and the
research team (see Appendix C). It was also distributed
via email to staﬀ and students at the University’s
School of Medicine, Medical Sciences and Nutrition
and captured opt-in respondents’ demographic charac-
teristics, smartphone usage, general fertility, FTA usage
and experiences using FTA data (see Appendix D for
survey questions). The survey was online for ﬁve days
(116 hours). Survey responses were anonymous unless a
participant volunteered to take part in a follow-up
interview, in which case a name (did not have to be
the respondent’s actual name) and email address was
collected to facilitate follow-up contact. These methods
of recruitment were chosen to allow for a more diverse
sample.20 Online distribution of surveys is becoming
popular and increasingly trusted.21 Social media was
used because of its ability to collect data rapidly and
cost-eﬀectively. Moreover, these methods allow
researchers to directly access prospective study partici-
pants who may be otherwise diﬃcult to reach (because
of their low prevalence or remote location).22 Informed
consent was implied from the completion of the survey.
Piloting the survey
The survey for this study was piloted among 10 col-
leagues of HMM and DJM, and clinicians from
Aberdeen Fertility Clinic whilst waiting for ethical
approval. This was deemed public involvement in
research for which ethics approval is not required.23
Their recommendations included changing wording
around sensitive questions and making clariﬁcations
around statements on the information page and changes
were adopted. In preparation for the interviews, a mock
interview was conducted among the research team.
Follow-up interviews. Follow-up interviews, based on
seeking clariﬁcation of open text answers to survey
questions from among respondents (‘can you tell me
more about . . .?’), took place with volunteers either
over the phone or on Skype (www.skype.com/en/),
were audio recorded and lasted 1015 minutes. The
interviews were transcribed and analysed immediately,
allowing data collection and analysis to build upon
each other in a grounded theory fashion.24 In line
with qualitative research conventions cited in the lit-
erature, the interview sample aimed for a total of
1320 interviews.25,26,27 Participants were purposively
selected for interviews based on their responses to the
survey to ensure diversity in viewpoints (a smaller
number of respondents who volunteered for an inter-
view were selected and approached based on data of
interest among the free-text responses, primarily to
clarify disconﬁrming data or to elicit more detailed
responses.). The last question of the survey oﬀered
respondents the opportunity to provide their email if
they were interested in participating in the follow-up
interview. Not all those who provided contact infor-
mation were contacted. Informed consent was also
taken for interviews. Potential participants were pro-
vided with an Information Sheet and Consent Form
by email (see Appendices D and E). Participation was
voluntary.
Inclusion and exclusion criteria
The same inclusion criteria applied for the online
survey and follow-up interviews. Those who wished to
contribute to this research must have met the following
inclusion criteria:
. Be 18 years of age and over;
. Be a woman;
. Have experienced current or previous menstruation.
It was not a requirement that participants had
experience using FTAs. Inclusion was based on self-
reported information oﬀered by participants.
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Data analysis
Online survey. Data was exported to IBM SPSS
Statistics (www.ibm.com/spss) Version 24 where it
was coded and cleaned for analysis. Frequencies and
percentages were calculated for ﬁxed response items
and free-text questions were coded and presented as
themes. Categorical responses were cross tabulated in
SPSS and chi-squared tests were performed to check for
associations between them following generation of
hypotheses from interview data.
Follow-up interviews. Analysis of the follow-up inter-
view data utilised a grounded theory approach.24
This approach allowed for systematic and rigorous
data collection with minimal preconceived ideas of
what the results might produce whilst using an
inductive analysis to generate theories. After each
interview, the audio ﬁle was listened to and the inter-
view was transcribed. A preliminary analysis was per-
formed to identify emerging categories. This
preliminary analysis was used to gather additional
data from subsequent interviews. After all the inter-
views had been completed, a ﬁnal analysis was carried
out. Open coding of all the interview transcriptions
was carried out by two persons. Interviews were ana-
lysed within and then across cases using open coding
techniques to identify overall subthemes. Then a
search was made for relations between the interviews
and these subthemes were accepted or rejected
according to new data. When reoccurring subthemes
were identiﬁed, they were synthesised into four
broader themes. This informed the formation of
hypotheses that were tested using the quantitative
data and chi-squared tests.
Results
Survey results
Sample demographics. The survey yielded 241 responses.
We discarded one response so all sample demo-
graphics should be out of 240. We have doubled
checked and they are all calculated out of 240. The
mean age of the respondents was 29 years (range
1861). The majority of respondents were educated
to undergraduate level (n¼ 111, 46%) and were
white (n¼ 220, 92%). Most of the respondents were
from the UK (n¼ 195, 81%) although the survey
received a global response. See Table 1 for demo-
graphic information.
Smartphone/tablet usage. Of the respondents, 98%
(n¼ 236) have a smartphone or tablet and 94%
(n¼ 227) used it to seek health information.
Table 1. Demographics of the respondents.
Demographic n (%)
Age group (years)
1724 115 (47.9)
2536 88 (36.7)
3742 16 (6.7)
4348 5 (2.1)
4954 9 (3.8)
5561 7 (2.9)
Home country
UK 195 (81.3)
Ireland 25 (10.4)
USA 9 (3.8)
Australia 2 (0.8)
Canada 2 (0.8)
Norway 2 (0.8)
China 1 (0.4)
Finland 1 (0.4)
Italy 1 (0.4)
South Africa 1 (0.4)
Switzerland 1 (0.4)
Education
Secondary level 63 (26.3)
Undergraduate 111 (46.3)
Postgraduate 66 (27.5)
Ethnicity
White 220 (91.7)
Mixed 8 (3.3)
Asian 7 (2.9)
Black 2 (0.8)
Other ethnicity/Arab 2 (0.8)
Prefer not to say 1 (0.4)
Total 240 (100.0)
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The majority reported using their smartphone to look
up health information between 1 and 2 days a week and
every few weeks. Over half of the respondents (n¼ 154,
64%) reported using health apps.
General fertility. The following section of the survey was
completed by 236 out of 241 (98%) participants.
Almost a third reported that they have regular periods
(n¼ 144, 61%), and 19% (n¼ 45) reported that they
have irregular periods; 11% (n¼ 26) reported that
they used to have periods but do not currently
and 8% (n¼ 19) selected other (when asked to specify,
responses were: use contraception that stops or regu-
lates periods; currently pregnant or just had a baby;
were menopausal; or had hysterectomy for irregular,
heavy periods). Over half (n¼ 137, 58%) of respond-
ents reported that they were using contraception (such
as the oral contraceptive pill, the contraceptive implant,
the contraceptive injection, an IUD or the barrier
method), and 42% (n¼ 99) reported that they were not.
FTA usage. Out of the 236 respondents to this section,
almost two-thirds reported that they do not use FTAs
(n¼ 146, 62%) and 38% (n¼ 89) reported using them.
Of the 89 women who reported using FTAs, Clue was
the most popular app as 12% (n¼ 11) of respondents
reported using it. The average frequency of FTA usage
was between 1 and 2 days a week (n¼ 18, 20%) and
every few weeks (n¼ 35, 39%). Some women also
reported using the apps several times a day (n¼ 5,
6%), about once a day (n¼ 14, 16%), 35 days a
week (n¼ 12, 14%) and less often than every few
weeks (n¼ 4, 5%).
Experience of FTAs. From the survey data, four main
motivations for the use of FTAs were:
1. To observe cycle (n¼ 63, 72%);
2. To conceive (n¼ 30, 34%);
3. To inform fertility treatment (n¼ 10, 12%);
4. As contraception (n¼ 3, 4%).
A total of 11% of respondents reported ‘other’
reason for use. Some examples of these included: to
be prepared for menstruation; to track hormonal acne
and mood swings; monitoring successful conception;
and trying to see patterns to link to other symptoms.
These reasons were not recoded to ﬁt with our options
given that participants chose to select other and provide
additional text.
A number of respondents reported not sharing their
data with anyone (43%, n¼ 38). Other responses were:
share with partner (39%, n¼ 35); share with family and
friends (10%, n¼ 9); share with healthcare professional
(18%, n¼ 16); share with fertility specialist (10%,
n¼ 9); and share with online community (2%, n¼ 2).
A few respondents reported using more than one
app (n¼ 7) to compare the accuracy of data, to deter-
mine their consistency and to see what other apps oﬀer.
Of the 89 respondents who reported using FTAs,
98% ﬁnd the apps useful. There were 73 open text com-
ments as to how and why the apps are useful/not useful.
They were coded as in Table 2.
When asked if they would make any changes to the
apps they are using, 30 respondents provided sugges-
tions. These responses were coded according to emer-
ging themes, which can be seen in Table 3.
Table 2. Responses to Q15 ‘Why do you find the app useful/not useful?’ coded into themes.
‘Useful’ Themes ‘Not Useful’ Themes
Tracking helps to be prepared/plan around period Inaccurate (usually reported in women with irregular periods)
Informative Upsetting and cause anxiety (usually in women
who are having fertility difficulties)
Tracking of other function e.g. sleep,
mood and see how it correlates to cycle
Reminders are annoying
Notifications and reminders
To maintain a history of cycles
Easy to store, access, share data
Predicts fertile days, can plan or avoid sex
Community provides reassurance
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When respondents selected ‘no’ to using FTAs they
were redirected to an open text question to explain why.
This question yielded 132 responses. These responses
were cleaned and coded into nine themes highlighted
in Table 4.
Of these respondents, 82% reported that they do not
use other methods to track fertility. Of the 18% who
reported using other methods, the majority use a paper
diary but they also use temperature charts, ovulation
testing kits, phone calendars and fertility monitors.
Follow-up interview results
Sample. Of the 49 survey respondents who agreed to a
follow-up interview and provided their email address,
16 women were contacted and invited for an interview.
Eleven responded to the request. Participant codes have
been assigned to protect participant identity. Table 5
gives an overview of the characteristics of the inter-
viewees. Themes that were identiﬁed are presented in
Table 6. Of the 11 interviews, there were two outliers
that interested the research team. Since they did not ﬁt
into the coding frame which emerged from the majority
of participant data, these interviews have been pre-
sented as two individual case studies (see Table 7).
Medical grounding (science and evidence-based)
It was important to women that the apps were ‘medic-
ally sound’ (FTA078) because many use them to track
other health factors. FTA214 said she uses ‘Clue
because I have some ongoing medical problems that my
doctor thinks is related to hormones’. FTA184 expressed
that due to a medical condition, it was important to be
able to track how heavy/light her periods were as ‘It’s
not the easiest thing to see in your mind’. FTA113 said
that she was diagnosed with premenstrual dysphoric
disorder and to be able to diagnose it you have to dili-
gently track your cycle ‘I did that for my doctor’s sake so
I used the app’.
Prediction. Accuracy of menstrual cycle prediction was
very important for most of the interviewees. They rely
on the apps so they could be prepared for their periods;
‘it makes it so easy so I do not get surprised’ (FTA058)
or for planning purposes; ‘I suﬀer from heavy and pain-
ful periods so it’s to keep track so I do not schedule things
when I know it’s due’ (FTA214). Those with regular
cycles were generally satisﬁed with the accuracy of pre-
diction of the apps that they used; ‘they seem to be able
to do a really good job in being able to predict when your
period is coming next’ (FTA078). However, those with
irregular cycles expressed frustration that their app was
not individualised to their own cycle; ‘what I’d quite like
it to do is . . . to work out some sort of prediction rather
than just go oﬀ a block of 28 days’ (FTA181). Women
also expressed an interest in learning how the prediction
methods work to see if they were personalised based on
their own data or whether they were just based on a
generic average cycle prediction; ‘it would be interesting
to see how their prediction methods work. I wonder if it’s
based on my last entry or a series of entries that they
predict my next one’ (FTA051).
Table 3. Recommended changes to FTAs coded into 12 main
themes.
1 Eliminate ads
2 Add more mood choices
3 Make it easier to log data
4 More information (links to current research, relevant forums,
fertility information, contraception information,
general women’s health information)
5 Improved accuracy
6 Features for someone going through fertility treatment
7 Add reminders
8 Add note-taking feature
9 More specialised recommendations
10 Link to other health apps
11 Manually adjust data
12 Change design
Table 4. Responses to Q18 ‘If you do not use FTAs, please explain
why’ coded into nine themes.
1 Never knew about them
2 On contraception or not sexually active  do not see the need
3 Haven’t found one to use that I like yet
4 Menopausal or sterilised
5 Do not trust them
6 Use a diary/regular calendar
7 Apps are not user friendly/do not like them
8 Terrible with technology/do not have phone storage space
9 Too stressful/too much pressure (for women trying
to get pregnant)
6 Digital Health 0(0)
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Contraception. Of the 11 interviewees, two expressed an
interest in using FTAs as a form of contraception; ‘I’ve
never really tried that form of contraception but I’d be
interested in trying that at some point’ (FTA078).
FTA124 said she doesn’t currently use FTAs but
expressed interest in coming oﬀ the oral contraceptive
pill and switching to using Natural Cycles as a form of
contraception; ‘ It’s safe, from what I’ve read, it’s pretty
accurate and I do not see why not to give it a try’
(FTA124).
In contrast, FTA113 expressed concern over using
an app as a form of contraception because she knows
people who got pregnant whilst using Natural Cycles as
contraception; ‘I have two friends who have become
pregnant using it even though they were really
careful . . . So I obviously have a really negative view of
that as a method’.
Education. Manywomen found the apps educational and
admitted that this was the ﬁrst time they have truly
Table 6. Subthemes and final themes that emerged from coding
interviews.
Final Coding Framework Initial Coding Framework
1. Medical grounding
(science and evidence-based)
 Prediction
 Contraception
 Education
2. Health trackers versus
non-trackers
 Early adopter and
data reviewing
 First timer
 Phone-in-hand
3. Design (content and delivery)  Commercialisation
 Data entry and notes
 ‘Pinkification’
 Additional features
4. Social and ethical aspects  Social recommendations
 Data sharing
 Scepticism
Table 7. Interview case studies of the ‘dystopian’ versus the ‘indifferent’.
The Dystopian Case The Indifferent Case
Social Used Google calendar to log previously
Specific app was recommended through online forum
Did not track her cycle previously
Recommended by mother to track
irregular periods
Data sharing App was recommended through online forum Did not share data
Relationship with
app and body
Developed strange relationship with body:
‘I felt like I was constantly under surveillance to a point where . . . I was just a bit
obsessed with the fluctuations, with the accuracy of my temping, it just brought
me into line with my bodily functions a little bit too closely to the point where it
just wasn’t enjoyable at all’
No comment
Stopped use ‘It was completely disempowering!’
Deleted app after husband’s recommendation:
‘I have stopped all monitoring now’
Kept forgetting to enter data and
did not see the need for it so
stopped using
Evidence-based science ‘I do think it’s based on the 28-day model still and a lot of the things are . . . it’s just
a really imperfect science and it makes you invest and trust it when actually I’m
not the best person to be monitoring those things’
No comment
Trust and scepticism Would purposely enter data wrong e.g. round up temperature data ‘’cause I
wanted to see my graph peak so then you think I’m not ever recording accurate
data here, I want to see an ovulation and was being incredibly emotional in my
use of the technology’
Was not able to predict irregular-
ity accurately
Emotion and attitude
towards apps
Thought it was ‘so unethical and not very scientific’
‘I think the kind of production of data on the body is problematic and I think it
makes trying for a baby a lot harder.’
Nonchalant, not bothered that it
did not work for her
Would laugh and refer to herself
as too forgetful
Can see the benefit ‘I imagine that if you use them and become pregnant in the start of your journey
then they’re great’
Can see why it is helpful but was
not for her
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understood their own bodies. FTA078 expressed ‘I think
I’ve learned more about my own reproductive system
through this app than anything else’ as did FTA113; ‘I
didn’t know anything about my cycle before I started using
the app’. One woman reported that ‘since using Clue I’ve
realised I have ovulation pain’ (FTA058). The use of the
apps is allowing women to better understand each stage
of their cycle and to ﬁnd correlations between their cycle
and symptoms.
Health trackers versus non-trackers
Early adopter and data reviewing. Three interviewees
reported using FTAs long-term; ‘I’ve used menstrual
calendar for about 9 years’ (FTA184). FTA181 said
she’s used MyCalendar for ‘about 4 or 5 years’.
FTA193 said that she has had ‘a few others . . . going
back to like 2012’. Interestingly, the three women who
were early adopters of the apps all reported that they
like to go back and review their data; ‘It’s reassuring
that I can just ﬂick back and see it’ (FTA184). FTA184
stated that she could go back to her data when she
previously became pregnant; ‘I like to compare it’.
First timer. Of the 11 interviewees, six reported that
using FTAs was their ﬁrst time tracking their periods;
‘using Clue is the ﬁrst time I’ve ever tracked before’
(FTA214). A lot of women reported that they were
ﬁrst-time trackers.
Phone-in-hand. It emerged that women like to use apps
on their phones to record their menstrual cycle data
because it is convenient; ‘my phone is in my hand 24
hours a day so I said I’d see what apps are available’
(FTA214). Accessibility was another feature that
made tracking on a smartphone desirable; ‘I like
having it in my pocket wherever I am’ (FTA051).
Design (content and delivery)
Commercialisation. Three women discussed advertise-
ments in their interviews. FTA113 didn’t seem too con-
cerned that the apps she uses ‘has some ads’; however,
FTA051 stated that she ‘had a diﬀerent app before but it
had pop up ads’ which she disliked and made her change
to using a diﬀerent app. FTA078 liked that Clue did
not ‘try to get you to buy any extras’. There was a trend
in women who were using the app to observe their cycle
to keep their data private and inconspicuous; ‘it’s more
discreet to have Clue that just looks like a health app . . . I
like that it sits next to my Apple Health and is a similar
design . . . like kind of medical . . .makes me feel like I’m
just tracking my health’ (FTA051). One women
expressed concern over the designers of these apps
not listening to the recommendations of users; ‘I just
wonder what kind of patient-public interaction there is
with the designers’ (FTA214).
Data entry and notes. Generally, women were very posi-
tive about the ease of entering data into their app; ‘if
you forget to track it’s easy to go back and put that data
in’ (FTA078). Adding notes was a key feature that
women found important when the standard format of
the app did not allow them to input all data that they
felt was relevant; ‘I add notes like there’s no tomorrow’
(FTA184). Interestingly the two women who were using
apps to try to conceive were the only women who used
the apps extremely diligently. The other women had a
more nonchalant approach to entering data often
reporting that they would forget to enter data; ‘I do
not use it religiously, I try to put in my dates and some-
times add in notes’ (FTA181).
‘Pinkification’ (i.e. the use of traditionally feminine design
features). Two women commented on the gendered
design of most FTAs. FTA092 commented that
‘I chose Clue because it’s the only app that wasn’t
pink’. FTA051 also found the gendered design of her
previous app insulting; ‘my last app had a pink ﬂower
and was called MyDays or something . . . I felt like they
were trying to lure me in with this kind of ‘‘women’s’’
approach’ (FTA051). She subsequently stopped using
that app and downloaded Clue.
Additional features. Some FTAs have features to track
other determinants of health such as diet, exercise,
mood, sleep and sexual activity. Six women mentioned
that they liked the additional tracking options that their
apps oﬀered. FTA051 said ‘you can track your hair,
skin, diet, exercise . . . all those lifestyle things . . . I can
look at Clue and see when I’ve been drinking or eating
lots of bad food . . . I appreciate the scope that Clue
oﬀers’. Similarly FTA184 said that ‘tracking my
weight is a big thing for me’. Some women often
found that their cycle is correlated with their mood;
‘my mood is very dependent on my cycle . . . I use it to
track that to understand myself better’ (FTA113).
FTA058 recognised the beneﬁt of tracking other
aspects of health; ‘you can track loads of stuﬀ on it
but also you do not have to’. She liked that her app
didn’t pester her with ‘a pop up of like ‘‘do not forget
to track how much water you’ve drank today’’’ and
appreciated that you had the option to track lots of
bodily functions or simply ‘what days you are on your
period which is nice’.
Social and ethical aspects
These aspects of using FTAs remain poorly understood
and under-regulated. Women are beginning to discuss if
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and how FTAs share their data. Most women were
unaware of how their data was being utilised by the
app owners and were unbothered ‘if anyone is desperate
to know when my periods are then I really do not care’
(FTA181). Only one woman expressed suspicion about
her data privacy and admitted to registering with an
alternative email address. She also claimed that ‘I do
not put in my exact date of birth, I put in the right year
but swap month and date, put in my middle name and
married name . . . I think I’m being very clever’
(FTA214).
Social recommendations. Two women reported that their
mother had recommended that they start tracking but
not speciﬁcally via an app. Two others said that the app
Clue was recommended by a friend. One woman came
across an app recommended on an online forum and
another woman saw Natural Cycles advertised on
social media. The remaining women discovered the
apps on their own after a recommendation from their
doctor to start tracking their cycles. This is evidence of
the fact that discussing periods is becoming less of a
taboo and women are sharing their tracking practices
in their social circles both in person and online.
Data sharing. The majority of women reported tracking
their cycles so they could share their data with a
healthcare professional or to have as a precautionary
measure; ‘It’s deﬁnitely helpful for doctor’s
appointments’ (FTA078) and FTA058 said ‘If my
gynaecologist needed to know anything I have it just in
case’. One survey respondent said that she is not cur-
rently sharing her data but she ‘intends to use it to start
a conversation with her doctor’ (FTA214). Interestingly,
FTA184 said that she is not taken as seriously by her
doctor unless she has her app data as proof; ‘I can go to
my doctor and it’s nice to be solid on the data . . .You
tend to get ignored if you do not have data to back your-
self up’.
Women reported sharing data with family and
friends but in a casual way that does not involve show-
ing them speciﬁc details of the app; ‘It’s helpful to give
family and friend a heads up to know if I’ll be a bit sad or
down’ (FTA113) and to compare their app and data
tracking with others; ‘It’s helpful to see how other
women are tracking their cycle’ (FTA051).
Scepticism. The two women trying to conceive expressed
the most scepticism about the accuracy and reliability
of the apps; ‘It’s just a really imperfect science . . . so
unethical and not very scientiﬁc’ (FTA193) and
FTA184 says ‘I do not trust Yono . . . I do not think
they’ve found a way what they’ve decided is your Basal
Body Temperature (BBT) from the ear results . . . I trust
mouth temperature more’.
Interview case studies
There were two outliers that did not ﬁt into the coding
frame which emerged from the majority of participant
data; these interviews have been presented as two indi-
vidual case studies (see Table 7). They are the only two
interviewees who reported giving up using the apps, but
for very diﬀerent reasons. They have been identiﬁed as
the dystopian case and the indiﬀerent case. The former
is an example of someone who has been obsessed by
and consumed with tracking her fertility to the point
where she found it unethical, unscientiﬁc and detrimen-
tal to her health. The latter found the app unhelpful
because she simply forgot to update it and seemed unaf-
fected by the fact that the app did not suit her needs.
Hypotheses testing. Once the interview data was analysed
and themes began to emerge the researchers formed
four hypotheses and tested them in the quantitative
survey data (see Table 8). Hypothesis, null hypothesis,
result and explanation are all reported. To better
understand why women were/were not using FTAs,
FTA usage was cross tabulated with health app
usage, birth control usage, age group and menstrual
status.
Discussion
Summary of findings
This study produced novel ﬁndings on women’s uses of
and relationships with FTAs. The survey was only live
for ﬁve days, but received a good response (n¼ 241).
Volunteers for interviews were forthcoming, perhaps
because more women are beginning to use FTAs and
want to share their experiences and views.
Four main uses of FTAs were identiﬁed: to observe;
to conceive; to inform fertility treatment; and as contra-
ception. Women suggested many changes to the apps
they use. This indicates that there are a range of motiv-
ations for use and that needs vary greatly between users.
It is important to note that 82% of women who use
FTAs reported that they had not previously used
another form of fertility tracking. Findings comparable
with ours were reported from a survey study of 310
women in 2015, although the survey was conducted
face to face and speciﬁcally among women seeking fer-
tility treatment.28 Conversely, it found that younger
women who are trying to become pregnant and who
have regular cycles are more likely than other women
to use smartphone apps. Further data was obtained
from a large-scale US study of over one million
women who use fertility tracking smartphone apps,
although the relationship between tracking and motiv-
ation for use is unclear from the published abstract.29
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Follow-up interviews. The follow-up interviews provided
deeper insights. The themes that were identiﬁed high-
lighted that women seek FTAs with more accurate pre-
diction methods and more information. Women felt
FTAs oﬀer the best method to track fertility because
of the large amount of data they can store and the
convenient accessibility that smartphones provide.
There was a level of dissatisfaction when it came to
design. Most women had suggestions about how to
improve both the content and delivery of these apps.
The two case studies reinforced the ﬁnding that users
have varying motivations and needs which could be met
if apps were more customisable to the individual.
Lupton2 claimed that health apps can empower users
to monitor and manage their own health but this is
clearly not the case for all users.
Hypotheses
Hypothesis 1. Women who use health apps are more
likely to use FTAs than women who do not use
health apps. Self-tracking is an interlinked community
and often if you track one determinant of health, you
are likely to track others. It is still unknown whether
women are using health apps as a gateway to fertility
tracking or vice versa.
Hypothesis 2. Among women who use contraception,
the majority are less likely to use FTAs than women
who do not use contraception. This may be because
many types of birth control regulate the menstrual
cycle so a woman using birth control may not feel the
need to track.
Table 8. Hypotheses that were formed after analysis of follow-up interview data.
Hypothesis 1 Women who use health apps are more likely to use FTAs than women who do not use health apps
Null Hypothesis 1 There is no association between FTA usage and health app usage
Result 1 Reject null hypothesis (2¼ 24.153, df¼ 1, p¼ 0.001)
Explanation 1 Out of 154 women who use health apps, 76 also use FTAs (49%). Out of 82 women who do not use health apps, 13 use FTAs
(16%). This difference was significant (2¼ 24.153, df¼ 1, p¼ 0.001).
Hypothesis 2 Women using contraception are less likely to use FTAs
Null Hypothesis 2 Birth control use does not affect FTA use
Result 2 Reject null hypothesis (2¼ 9.897, df¼ 1, p¼ 0.002)
Explanation 2 Of the women using birth control, 40 (29%) reported using FTAs.
Of the women that do not use birth control, 49 (50%) used FTAs. This association was significant (2¼ 9.897, df¼ 1, p¼ 0.002).
Perhaps this is because many types of birth control regulate the menstrual cycle so a woman using birth control may not
feel the need to track.
Hypothesis 3 Younger women are more likely to use FTAs than older women
Null Hypothesis 3 There is no relationship between FTA usage and age
Result 3 Reject null hypothesis (2¼ 27.206, df¼ 5, p¼ 0.001)
Explanation 3 Of the women aged 1824, 28% used FTAs; of women aged 2532, 45% used FTAs; of women aged 3339, 67% used FTAs; of
women over 40, 20% used FTAs.
This trend shows that as age increases, FTA usage increases until the age of 40 when it decreases. This relationship is
significant (2¼ 27.206, df¼ 5, p¼ 0.001).
Hypothesis 4 Women with regular menstrual cycles are more likely to use FTAs that women with irregular cycles
Null Hypothesis 4 There is no relationship between FTA usage and menstrual status
Result 4 Accept null hypothesis (2¼ 5.293, df¼ 4, p¼ 0.259)
Explanation 4 There is no association between the use of FTAs and menstrual status, e.g. regular/irregular periods. Of the women who have
regular periods, 60 (42%) reported using FTAs. Of the women who had irregular periods, 40% reported using FTAs. The
difference was not significant (2¼ 5.293, df¼ 4, p¼ 0.259).
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Hypothesis 3. Women use FTAsmore up until 40 years of
age, when its use decreases. This may be because
younger women engage more with technology and use
dips as perceived childbearing age decreases. FTAs must
not be dismissed for older women as they could also be
useful to track fertility in later onset treatment or to
record changes as a woman goes through menopause.
Hypothesis 4. There was no association found between
the use of FTAs and menstrual status, e.g. regular/
irregular periods. Women with irregular cycles are
still using FTAs even though they feel like they do
not meet their needs. This further demonstrates that
women with varying motivations are still using FTAs
and their needs should be met.
Implications of findings
Women’s uses of and relationships with FTAs have
implications for various stakeholders, introduced
below. Collaboration between stakeholders is necessary
to satisfy user needs. Some extensions of our analyses
and speculations as to how are presented.
Implications for reproductive health services. Healthcare
professionals providing care and support for women
need to take women’s app use into account and recog-
nise both the potential and limitations of these apps.
Tracking via apps has helped women in this study
notice menstrual irregularities that they have then dis-
cussed with their doctors. Recommendations to health
care providers to guide their support of FTA users has
been developed.16 Calls for users to be supported
appropriately16 to avoid their health and wellbeing
being compromised30 have been made. One nursing
practice study highlights the need for nurses to explore
available apps, incorporate their use into practice and
share insights with peers to develop practical know-
ledge.31 This is not just for fertility awareness, but for
reproductive health more broadly.
Implications for regulators. A concern with commercial
apps is that they are not regulated or approved for
use by oﬃcial bodies (with the exception of Natural
Cycles), but consumers may erroneously assume that
they are. There are hundreds of FTAs available and
they vary widely in their prediction methods and accur-
acy. There are ethical and privacy issues surrounding
the data they collect. For example, commercial apps
could sell users’ data to third parties, including employ-
ers, which may have implications for menstrual leave
and/or maternity leave.
Implications for developers. Smartphones are now an
extension of our bodies. Our relationship with
technology is obsessive and we are generating/consum-
ing more data than ever before. This study found that
many women do not track their fertility using an app.
With the rising use of health apps, developers might
beneﬁt from keeping their audiences’ needs in mind,
or consulting them when designing FTAs. Services
might also consider partnering with providers of apps
or designing their own apps to ensure a two-way ﬂow of
evidence and information can improve apps and
knowledge.
App developers should provide the most accurate
prediction methods possible. There are many external
factors that can aﬀect a woman’s cycle and developers
should take these into consideration and allow women
to manually adjust data. FTAs should be designed for
customisation. When setting them up, a woman should
be asked more speciﬁc questions with a wider range of
options about how she would like her app to be
designed, what level of extra features she would like,
what type of user she is and so on. This recommenda-
tion that apps must be aimed at a wider audience is
in line with Lupton’s recommendations ‘that further
research/consideration is needed for marginalised
groups such as lesbian, gay, bisexual or transgender
(LGBT) people, or diﬀering socio-economic back-
grounds’ regarding pregnancy apps and health apps
in general.13,32 Developers should also consider creat-
ing professional and gender-neutral app layouts to sup-
port the various types of user, e.g. not pink and ﬂowery.
Women’s needs
Women in this study expressed interest in tracking
symptoms, such as mood, skin, diet and exercise.
Perhaps they are using FTAs as a gateway to tracking
other determinants of health. If this is the case then
there should be better interoperability between various
health apps so data can be collected and transferred
easily.
Comparedwith other determinants of health, e.g. life-
style choices, fertility tracking is very diﬀerent. Women
do not have any control over their menstrual cycles.
However, the importance of simply tracking to observe,
rather than to motivate behaviour change/inﬂuence out-
comes, must not be overlooked. Observing can help
women to understand their symptoms and sometimes
explain causes and lead to diagnosis.
Many participants reported that using FTAs were
informative and educational. Women are only formally
taught about their reproductive health as children when
it can be an uncomfortable topic to discuss. FTAs give
women the opportunity to learn about their own bodies
in a safe environment. If FTAs are meeting the educa-
tional needs of so many women then perhaps some apps
should have a feature for younger prepubescent women
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who may want to educate themselves in a private and
safe environment. Graphics and colours are considered
to be important and although our study found that ‘pin-
kiﬁcation’ was not attractive, another study referred to
‘pink and lovely graphics’ as appealing.31
Limitations of study
The main limitation of this study is that the sample size
of the survey portion of the study is very small, even
ignoring the fact that only 89 of the 241 respondents
actually used an FTA. In addition, we cannot be sure
that women’s attitudes to FTAs can be disentangled
from their view of their eﬀectiveness.
Furthermore, this study used a convenience sample
so the ﬁndings are not generalisable for all consumers
of FTAs. It is also recognised that, in grounded theory,
sampling is not demographically representative. The
demographic makeup was heavily inﬂuenced by the
research team’s social media networks. This survey’s
sample was homogeneous: the majority were white,
from the UK and educated to undergraduate level. In
a future study it would be interesting to see if there were
diﬀering results across diﬀerent ages, education levels,
economic statuses, cultural groups and ethnic groups.
Receiving ethical approval took longer than
expected due to availability of board members (ﬁve as
opposed to the average length of two weeks). This lim-
ited the amount of time that the online survey was live:
for only ﬁve days. If it had been available online for
longer, it might have provided a larger and more demo-
graphically diverse sample.
Selecting the term ‘fertility tracking’ app as opposed
to ‘period tracking’ or ‘menstrual cycle tracking’ may
have had an eﬀect on the number of women who par-
ticipated in the study. Women who track with the aim
to observe their cycle, and who are not seeking to
become pregnant, may not identify with the word fer-
tility and may not feel it is applicable to them.
Strengths of study
By collecting complementary quantitative and qualita-
tive data, breadth and depth of understanding were
elicited. Mixed methods research provides a more com-
plete and comprehensive account of the research prob-
lem than either quantitative or qualitative approaches
alone. A mixed methods paradigm can strengthen the
quality of the research by combining the strengths of
each approach and mitigating the internal limitations
of each.33
When writing up the results, the researchers dis-
covered a similar study conducted by Epstein et al.34
in the USA. Although this study diﬀers in objectives
and methodology, these ﬁndings mirror many of their
ﬁndings, suggesting there is a level of consistency in
women’s relationships with and uses of FTAs.
Reflexivity and research team potential biases
It is important to note that the primary researcher is
using a form of contraception that has aﬀected her men-
strual cycle and has stopped her periods. Therefore, she
does not use any FTAs and has no preference towards a
particular app. Although she noticed a trend towards
Clue being the favourite app, she was able to remain
unbiased. The other female member of the research
team uses no hormonal contraception, but is an early
adopter and tech enthusiast and uses various apps,
including FTAs, for research purposes. Her regular
app is Clue and she has a paid subscription to Natural
Cycles. She has also tracked her menstrual cycles using
paper since ﬁrst menstruating and continues to do so.
Recommendations for future research
Future research should explore women’s uses of FTAs
across education level, economic status and cultural
and ethnic groups.
This study demonstrated that there are a range of
user groups who feel that their needs are not being met
by currently available FTAs. Most apps are designed
for narrow user groups, women who are healthy; are
sexually active; are heterosexual; have regular periods;
and have no fertility issues. Future research should con-
sider the needs of individuals who are:
. Infertile or struggling to conceive;
. Of non-normative gender identity;
. Experiencing other health concerns that impact
menstruation;
. Any sexuality other than heterosexual;
. Experiencing irregular periods.
Further research into the views of consumers of
these technologies can contribute to understandings of
how to create more user-friendly products that can
beneﬁt health and social care providers and consumers.
Conclusion
App developers and health services hoping to develop
clinically endorsed apps need to listen more to the
voices of their users and take their suggestions on
board when developing future FTAs to improve user
experience. Social and ethical aspects of FTAs are still
poorly understood and under-regulated. However, with
increasing use of FTAs7 and a general shift to providing
evidence-based healthcare via technology, there will be
increased onus on regulatory bodies.
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This research emphasises the importance of FTAs
being personalised to the individual to support the dif-
fering motivations of users. It recommended that app
developers design for accuracy, individualisation and
inclusion. Collaboration between various stakeholders
is also necessary to satisfy user needs. Future research
should focus on further exploring the dynamic relation-
ships between women and FTAs to inform health ser-
vices, regulators and app developers, and therefore
improve the experience for users of various menstrual
and/or birth control statuses and to support the inte-
gration of FTAs into health care.
Acknowledgement: Thanks to all participants in this research,
whose contributions to the development of this ﬁeld are invaluable.
Contributorship: KG-R led the design, conduct, analysis and writ-
ing. DJM supported substantive (fertility modelling) and methodo-
logical (statistics) work. HMM supervised the project and supported
substantive (digital health) and methodological (qualitative and
mixed methods research) work. All authors contributed to this manu-
script, agreed revisions based on peer review and all approved the
ﬁnal version.
Declaration of conflicting interests: The authors declare that
there are no conﬂicting interests.
Ethical approval: Ethical approval was sought from and granted
by the College of Life Sciences and Medicine Ethics Review Board
CERB/2017/2/1426 on 6 March 2017.
Funding: This work was conducted as a BSc (Hons) research pro-
ject at the University of Aberdeen. No external funding was received.
Guarantor: HMM is the guarantor.
Peer review: This manuscript was reviewed by three individuals
who have chosen to remain anonymous.
Supplementary Material: Supplementary material is available for
this article online.
ORCID iD
Katie Gambier-Ross http://orcid.org/0000-0002-5050-8051
David J McLernon http://orcid.org/0000-0001-8905-2429
Heather M Morgan http://orcid.org/0000-0002-6118-8911
References
1. Lupton D. Towards critical digital health studies: reflec-
tions on two decades of research in health and the way
forward. Health 2016; 20(1): 4961.
2. Lupton D. Quantifying the body: monitoring and measur-
ing health in the age of mHealth technologies. Crit Public
Health 2013; 23(4): 393403.
3. Krebs P and Duncan DT. Health app use among US
mobile phone owners: a national survey. JMIR mHealth
uHealth 2015; 3(4): e101.
4. Lupton D. Apps as artefacts: towards a critical perspective
on mobile health and medical apps. Societies 2014; 4(4):
606622.
5. Morgan H. ‘Pushed’ self-tracking using digital technolo-
gies for chronic health condition management: a critical
interpretive synthesis. Digital Health 2016; 2: 141.
6. Caddy B. The quantified woman: fertility tracking
and the future of our reproductive health. 2015.
Available at: https://www.wareable.com/health-and-well-
being/the-quantified-woman-fertility-tracking-1914
(accessed 16 February 2017).
7. Weigel M. ‘Fitbit for your period’: the rise of fertility
tracking. The Guardian, 2016. Available at: https://
www.theguardian.com/technology/2016/mar/23/fitbit-
for-your-period-the-rise-of-fertility-tracking (accessed 16
February 2017).
8. Grimes DA, Gallo MF, Halpern V, et al. Fertility aware-
ness-based methods for contraception. Cochrane Database
of Systematic Reviews, 2004. Available at: http://cochra-
nelibrary-wiley.com/doi/10.1002/
14651858.CD004860.pub2/pdf.
9. US Department of Health and Human Services.
Effectiveness of family planning methods. https://www.
cdc.gov/reproductivehealth/contraception/unintended-
pregnancy/pdf/Contraceptive_methods_508.pdf (2004,
accessed 17 March 2018).
10. Berglund Scherwitzl E, Gemzell Danielsson K, Sellberg
JA, et al. Fertility awareness-based mobile application for
contraception. Eur J Contracept Reprod Health Care
2016; 21(3): 234241.
11. Berglund Scherwitzl E, Lundberg O, Kopp Kallner H,
et al. Perfect-use and typical-use Pearl Index of a contra-
ceptive mobile app. Contraception 2017; 6, 420425.
12. Smith AD, Smith JL. billingsMentor: Adapting natural
family planning to information technology and relieving
the user of unnecessary tasks. Linacre Q 2014; 81(3): 219–
238.
13. Lupton D. Digital health now and in the future: findings
from a participatory stakeholder workshop. Digital
Health 2017; 3, 117.
14. Setton RMD, Tierney CMD and Tsai TMD. The accu-
racy of web sites and cellular phone applications in pre-
dicting the fertile window. Obstet Gynecol 2016; 128(1):
5863.
15. Brown S, Blackwell LF and Cooke DG. Online fertility
monitoring: some of the issues. Int J Open Inf Technol
2017; 5(4): 8591.
16. Moglia ML, Nguyen HV, Chyjek K, et al. Evaluation of
smartphone menstrual cycle tracking applications using
an adapted APPLICATIONS scoring system. Obstet
Gynecol 2016; 127(6): 11531160.
17. Wettstein H, Al-Shemmery Z and Bourgeois C. Natural
family planning: when smartphone and iPhones are used
for contraception. A comparison study of 7 symptother-
mal apps. Eur J Contracept Reprod Health Care 2014; 19:
S201.
18. Magistretti B. Natural Cycles is first contraceptive app to
get EU approval. Venture Beat, 2017. Available at: http://
venturebeat.com/2017/02/09/natural-cycles-is-first-con-
traceptive-app-to-get-eu-approval/ (accessed 20 March
2017).
19. Lupton D. Digital companion species and eating data:
implications for theorising digital data-human assem-
blages. Big Data & Society 2016; 3(1): 1–5.
20. Casler K, Bickel L and Hackett E. Separate but equal? A
comparison of participants and data gathered via
14 Digital Health 0(0)
Amazon’s MTurk, social media, and face-to-face
behavioral testing. Comput Hum Behav 2013; 29(6):
21562160.
21. Tuten TL, Urban DJ and Bosnjak M. Internet surveys
and data quality: a review. 2002. Available at: https://ub-
madoc.bib.uni-mannheim.de/8492/ (accessed 22 March
2017).
22. King DB, O’Rourke N and DeLongis A. Social media
recruitment and online data collection: a beginner’s
guide and best practices for accessing low-prevalence
and hard-to-reach populations. Can Psychol 2014;
55(4): 240249.
23. INVOLVE. Do I need to apply for ethical approval to
involve the public in my research? 2018; 201. http://www.
invo.org.uk/posttypefaq/do-i-need-to-apply-for-ethical-
approval-to-involve-the-public-in-my-research/#
(accessed 17 March 2018).
24. Glaser BG and Strauss AL. The discovery of grounded
theory. Int J Qual Methods 1967; 5: 110.
25. Francis JJ, Johnston M, Robertson C, et al. What is an
adequate sample size? Operationalising data saturation
for theory-based interview studies. Psychol Health 2010;
25(10): 12291245.
26. Mason M. Sample size and saturation in PhD studies
using qualitative interviews. Forum: Qualitative
Sozialforschung / Forum: Qualitative Social Research
2010; 11(3): Article 8.
27. Baker SE and Edwards R. How many qualitative inter-
views is enough? National Centre for Research Methods
Review Paper, 2012.
28. Lanham M and Christensen MA. Fertility-related smart-
phone application use among patients seeking treatment
for infertility. Fertil Steril 2015; 104(3): e354.
29. Lange A, Yeh J, Messerlian C, et al. Smartphone fertility
app use among couples of reproductive age: potential use
of big data to improve fertility care and advance repro-
ductive health research. Fertil Steril 2016; 106(3): e111.
30. Freundl G and Frank-Herrmann P. Natu¨rliche
Familienplanung. In: Gnoth C and Mallmann P (eds)
Perikonzeptionelle Frauenheilkunde. Berlin, Heidelberg:
Springer-Verlag, 2014, pp.1328.
31. McCartney P. Nursing practice with menstrual and ferti-
lity mobile apps. MCN Am J Matern Child Nurs 2016;
41(1): 61.
32. Lupton D. The use and value of digital media for infor-
mation about pregnancy and early motherhood: a focus
group study. BMC Pregnancy Childbirth 2016; 16: 171.
33. Johnson RB and Onwuegbuzie AJ. Mixed methods
research: a research paradigm whose time has come.
Educ Res 2004; 33(7): 1426.
34. Epstein DA, Lee NB, Kang JH, et al. Examining men-
strual tracking to inform the design of personal infor-
matics tools. Proc SIGCHI Conf Hum Factor Comput
Syst 2017; 2017:68766888.
Gambier-Ross et al. 15
